FDA Inspection 994363 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 1000161089

The FDA completed an inspection of Mary Bird Perkins Cancer Center on December 16, 2016 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 16, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)